Table 2.
Changes of DI during IT and at 1-year follow-up in the remission and nonremission groups compared with NGT and IGT subjects
| Diabetes |
NGT (n = 12) | IGT (n = 28) | ||
|---|---|---|---|---|
| Remission (n = 21) | Nonremission (n = 27) | |||
| DI | 331.5 (131.6–444.8) | 112.1 (69.2–216.2) | ||
| Before therapy | 11.7 (7.3–15.9)*† | 12.4 (9.2–16.2)*† | ||
| After therapy | 34.6 (31.2–61.2)*†‡ | 25.6 (21.5–33.6)*†‡§ | ||
| At 1 year | 41.2 (30.8–80.8)*†‡ | 21.3 (18.2–37.3)*†‡§ | ||
Data for DI are logarithm-transformed for analysis and expressed as median (IQR).
*P < 0.01 vs. NGT.
†P < 0.01 vs. IGT.
‡P < 0.01 vs. before therapy, adjusted for BMI and age.
§P < 0.01 vs. remission group.